Cargando…
Enhanced Anti-Brain Metastasis from Non-Small Cell Lung Cancer of Osimertinib and Doxorubicin Co-Delivery Targeted Nanocarrier
PURPOSE: Currently, the treatment of brain metastases from non-small cell lung cancer (NSCLC) is rather difficult in the clinic. A combination of small molecule-targeted drug and chemo-drug is a promising therapeutic strategy for the treatment of NSCLC brain metastases. But the efficacy of this comb...
Autores principales: | Wang, Xiaoqi, Mao, Wenxing, Wang, Zhi, Li, Xinrui, Xiong, Yaokun, Lu, Hongjin, Wang, Xiuzhen, Yin, Haoyuan, Cao, Xiang, Xin, Hongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425109/ https://www.ncbi.nlm.nih.gov/pubmed/32848385 http://dx.doi.org/10.2147/IJN.S258699 |
Ejemplares similares
-
A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis
por: Wei, Zeliang, et al.
Publicado: (2020) -
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells
por: Ziganshina, Albina Y., et al.
Publicado: (2023) -
Targeted Delivery of Doxorubicin by Folic Acid-Decorated
Dual Functional Nanocarrier
por: Lu, Jianqin, et al.
Publicado: (2014) -
Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
por: Guo, Wei, et al.
Publicado: (2020) -
Correction to “Targeted Delivery of Doxorubicin
by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019)